Related Experiment Video
Updated: Jul 9, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Clinical applications of gene therapy in head and neck cancer
Michalis V Karamouzis1, Athanassios Argiris, Jennifer Rubin Grandis
1Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Abstract:
Despite advances in surgery, radiotherapy, and the incorporation of novel systemic agents into treatment, long-term outcomes of patients with head and neck cancer remain unsatisfactory. The growing understanding of head and neck cancer biology suggests that targeting molecular events governing carcinogenesis or tumor progression may provide novel therapeutic approaches for head and neck cancer. Squamous cell carcinoma of the head and neck (SCCHN) is characterized by locoregional spread and is clinically accessible, making it an attractive target for intratumoral gene therapy, a potentially efficacious experimental treatment. Systemic delivery of gene therapy may be also possible, albeit with several limitations. In this review we will discuss the rationale, delivery methods, and accumulated clinical data with cancer gene therapy in SCCHN.
Insights
Gene therapy offers a promising approach for head and neck cancer, particularly squamous cell carcinoma of the head and neck (SCCHN). This review explores the rationale, delivery methods, and clinical data for gene therapy in SCCHN treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Despite treatment advances, head and neck cancer outcomes remain poor.
- Understanding cancer biology reveals molecular targets for novel therapies.
- Squamous cell carcinoma of the head and neck (SCCHN) is accessible for localized treatment.
Purpose of the Study:
- To review the rationale for gene therapy in SCCHN.
- To discuss various gene therapy delivery methods.
- To summarize accumulated clinical data on gene therapy for SCCHN.
Main Methods:
- Literature review of gene therapy in head and neck cancer.
- Analysis of studies focusing on SCCHN.
- Evaluation of intratumoral and systemic gene delivery approaches.
Main Results:
- Gene therapy presents a potentially effective experimental treatment for SCCHN.
- Intratumoral delivery is a viable strategy due to SCCHN's accessibility.
- Systemic delivery faces limitations but is also explored.
Conclusions:
- Targeting molecular events in SCCHN is a key therapeutic strategy.
- Gene therapy, especially intratumoral, shows promise for SCCHN.
- Further research and clinical data are needed to optimize gene therapy outcomes.
More Related Videos
Related Concept Videos
Gene Therapy
Gene Therapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics

